Closed
SectorHealthcare
318 -1.18
24h
Min
314.03
Max
322.53
Income | 26M -57M |
---|---|
Sales | 1M 594M |
EPS | -0.01 |
Profit margin | -9.674 |
Employees | 2,230 |
EBITDA | 166M 11M |
Recommendations | Strong Buy |
---|---|
12 Months Forecast | +3.85% upside |
Next Earnings | 31 Jul 2025 |
---|
Market Cap | 6.7B 41B |
---|---|
Previous open | 319.18 |
Previous close | 318 |
By Acuity
50%
50%
154 / 380 Healthcare
By Trading Central
Confidence
Bullish Evidence
Past performance is not a reliable indicator of future results.
Price change
By TipRanks
12 Months Forecast
Average 334.33 USD 3.85%
High 500 USD
Low 245 USD
Based on 22 Wall Street analysts offering 12 month price targets forAlnylam Pharmaceuticals Inc - Dist in the last 3 months.
By Acuity
News Sentiment
Neutral
Volatility
Below average
News Volume (RCV)
Above average
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$